Related Experiment Video
Updated: May 21, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Cognitive dysfunction in multiple sclerosis
Joana Guimarães1, Maria José Sá
1MS Clinic, Department of Neurology, Centro Hospitalar São João Porto, Portugal.
Frontiers in Neurology
|June 2, 2012
Summary
Cognitive impairment affects 45-60% of Multiple Sclerosis (MS) patients, with a specific pattern emerging. Early detection and intervention are crucial for managing MS cognitive dysfunction.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Science
Background:
- Multiple Sclerosis (MS) is associated with significant cognitive impairment in 45-60% of patients.
- Cognitive deficits in MS, once considered heterogeneous, now show a discernible pattern.
- Early detection of cognitive dysfunction is vital due to advancements in MS treatments.
Purpose of the Study:
- To review common cognitive domains affected in MS.
- To explore pathophysiological mechanisms and neuroimaging correlates of MS cognitive dysfunction.
- To discuss the importance of neuropsychological assessment and therapeutic strategies for cognitive improvement in MS.
Main Methods:
- Literature review of studies on cognitive impairment in Multiple Sclerosis.
- Analysis of pathophysiological mechanisms and brain MRI findings.
- Evaluation of neuropsychological assessment tools and therapeutic interventions.
Main Results:
- Key cognitive domains affected include memory, attention, executive functions, processing speed, and visual-spatial abilities.
- Specific pathophysiological mechanisms and MRI features are linked to MS cognitive dysfunction.
- Neuropsychological assessment is crucial across all disease stages, with disease course influencing performance.
Conclusions:
- A specific pattern of cognitive dysfunction exists in MS, necessitating targeted assessment.
- Understanding the underlying mechanisms and utilizing appropriate tests are key for effective management.
- Therapeutic strategies can be employed to enhance cognitive function in MS patients.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...